Evolus (EOLS) Operating Income Growth (5y) (2022 - 2026)
Evolus (EOLS) Operating Income Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Evolus | 402.53 Mn | 352.74 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.33% |
| Dec 31, 2025 | 15.32% |
| Sep 30, 2025 | -5.59% |
| Jun 30, 2025 | 11.58% |
| Mar 31, 2025 | 2.70% |
| Dec 31, 2024 | 28.68% |
| Sep 30, 2024 | 9.25% |
| Jun 30, 2024 | 26.54% |
| Mar 31, 2024 | 18.80% |
| Dec 31, 2023 | 7.14% |
| Sep 30, 2023 | -3.19% |
| Jun 30, 2023 | 1.25% |
| Mar 31, 2023 | -14.77% |
| Dec 31, 2022 | -30.06% |
| Sep 30, 2022 | -46.90% |
| Jun 30, 2022 | -56.49% |
| Mar 31, 2022 | -31.18% |